IP Library Granted Patent US 7,473,477
Granted Patent B2
US 7,473,477 · App. 11/095,165 · Granted Jan 6, 2009

Phosphorescent iridium complexes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,473,477
App. No.
11/095,165
Granted
Jan 6, 2009
Kind
B2
Abstract

An OLED device comprises a cathode, an anode, and located therebetween a light emitting layer containing a compound represented by formula (I): A m -M-B n   (I) wherein m+n=2 or 3 and neither m nor n is 0; M is Ir, Pt, Os, Ru, Rh, or Pd; A m includes at least one ligand A having a triplet energy of at least 2.9 eV as measured in a homoleptic complex of M and A; and B is represented by the formula (II): wherein Q represents an atomic group forming a nitrogen-containing heterocyclic ring; and R5, R6, R7, R8 and R5′ independently represent a hydrogen atom or a substituent.

Claims (37)

1. An OLED device comprising a cathode, an anode, and located therebetween a light emitting layer containing a compound represented by formula (I):

A m -M-B n   (I)

wherein

m+n=2 or 3 and neither m nor n is 0;

M is Ir, Pt, Os, Ru, Rh, Re or Pd;

A m includes at least one ligand A having a triplet energy of at least 2.9 eV as measured in a homoleptic complex of M and A; and

B is represented by the formula (II):

wherein

Q represents an atomic group forming a nitrogen-containing heterocyclic ring; and R5, R6, R7, R8 and R5′ independently represent a hydrogen atom or a substituent; and

wherein at least one ligand A of formula (I) is a 1-phenylpyrazole group represented by formula (II):

wherein R 1 , R 2 , R 3 , R 4 , R 1 ′, R 2 ′, and R 3 ′ are each hydrogen or an independently selected substituent.

2. The device of claim 1 wherein ligand A has a triplet energy of at least 3.0 eV as measured in a homoleptic complex of M and A.

3. The device of claim 1 wherein ligand A has a triplet energy of at least 3.1 eV as measured in a homoleptic complex of M and A.

4. The device of claim 1 wherein at least one of R 1 , R 2 , R 3 , or R 4 is an electron withdrawing group having a positive Hammett's sigma para or meta value.

5. The device of claim 4 wherein the electron withdrawing group is selected from those having a Hammett's sigma pan or meta value of at least 0.3.

6. The device of claim 4 wherein the electron withdrawing group is selected from the group consisting of F, CF 3 , CN, NO 2 , C(O)OR, C(O)R, C(O)NR,P(O)RR′, P(S)RR′, SO 2 , SOR, SO 2 R, SO 3 R, BRR′, and B(OR) 2 groups wherein each R and R′ is a substituent.

7. The device of claim 1 wherein at least one R 1 ′, R 2 ′, or R 3 ′ is represented by an electron donating group having a negative Hanimett's sigma para or meta value.

8. The device of claim 7 wherein the electron donating group is selected from C 1 -C 20 alkyl, C 1 -C 20 alkoxy, NRR′, and thiophene groups wherein each R and R′ is a substituent.

9. The device of claim 1 wherein at least one ligand A of formula (I) is selected from the group consisting of:

10. The device of claim 1 wherein at least one ligand B of formula (I) is a pyridylpyrazole.

11. The device of claim 10 wherein ligand B is represented by formula (III):

wherein each R 5 , R 6 , R 7 , R 8 , R 5 ′, and R 6 ′ is independently a hydrogen or substituent.

12. The device of claim 11 wherein ligand B is independently substituted with at least one electron withdrawing group having a positive Hammett's sigma pam or meta value at R 5 ′, or R 6 ′.

13. The device of claim 12 wherein the electron withdrawing group is selected from those having a Hanimett's sigma para or meta value of at least 0.3.

14. The device of claim 13 wherein the electron withdrawing group is selected from the group consisting of F, CF 3 , CN, NO 2 , C(O)OR, C(O)R, C(O)NR,P(O)RR′, P(S)RR′, SO 2 , SOR, SO 2 R, SO 3 R, BRR′, and B(OR) 2 groups wherein each R and R′ is a substituent.

15. The device of claim 11 wherein ligand B is independently substituted with at least one electron donating group having a negative Rammett's sigma para or meta value at R 5 , R 6 , R 7 , or R 8 .

16. The device of claim 15 wherein the electron donating group is selected from C 1 -C 20 alkyl, C 1 -C 20 alkoxy, NRR′, and thiophene groups wherein each R and R′ is a substituent.

17. The device of claim 1 wherein ligand B of formula (I) is selected from the group consisting of:

18. The device of claim 1 wherein n is 2 and m is 1.

19. The device of claim 1 wherein n is 1 and m is 2.

20. The device of claim 1 wherein the device emits white light.

21. The device of claim 1 wherein the light emitted from the light-emitting layer is blue.

22. The device of claim 1 wherein the compound having formula (I) is in a layer which comprises a polymer.

23. The device of claim 1 wherein the compound having formula (I) is in a layer adjacent to a layer which comprises a polymer.

24. The device of claim 1 wherein the compound having formula (I) is polvmenc.

25. A stacked device comprising the device of claim 1 .

26. The device of claim 1 wherein the light emitting layer contains a host material that has a triplet energy higher than that of the compound having formula (I) and the host is selected from: 4,4′-N,N′-dicarbazole-biphenyl (CBP), 2,2′-dimethyl-4,4′-N, N′-dicarbazole-biphenyl, m-(N,N′-dicarbazole)benzene, poly(N-vinylcarbazole) compounds, diphenyldi(o-tolyl)silane and p-bis(triphenylsilyl)silane.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 26, 2010
From: EASTMAN KODAK COMPANY
To: GLOBAL OLED TECHNOLOGY LLC
Reel/Frame 023998/0368 →